Knight Therapeutics Inc (GUD.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 56,569 | 53,109 | 50,397 | 62,621 | 47,915 |
| Income taxes - deferred | -3,811 | -3,243 | -9,126 | -17,125 | -7,636 |
| Accounts receivable | -26,532 | -10,288 | 5,575 | -29,958 | 8,577 |
| Accounts payable and accrued liabilities | 42,105 | 632 | -21,629 | 30,601 | 11,455 |
| Other Working Capital | 1,894 | -19,624 | -28,013 | -9,989 | 627 |
| Other Operating Activity | -1,268 | 15,694 | 38,735 | 4,331 | -16,320 |
| Operating Cash Flow | $68,957 | $36,280 | $35,939 | $40,481 | $44,618 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,878 | -2,369 | 974 | -2,885 | -3,832 |
| Net Acquisitions | -110,081 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -70,394 | -162,570 | -334,163 | -185,473 | -64,321 |
| Sale Of Investment | 121,383 | 210,808 | 347,901 | 150,544 | 180,541 |
| Purchase Sale Intangibles | -31,786 | -29,003 | -9,008 | -22,931 | -220,351 |
| Other Investing Activity | 17,598 | 97 | 23,637 | -2,334 | 2,684 |
| Investing Cash Flow | $-75,158 | $16,963 | $29,341 | $-63,079 | $-105,279 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 112,070 | 3,473 | 4,796 | 51,783 | 9,423 |
| Debt Repayment | -91,545 | -21,524 | -22,820 | -20,292 | -23,615 |
| Common Stock Repurchased | -6,352 | -8,866 | -53,479 | -30,069 | -64,415 |
| Other Financing Activity | -8,767 | -6,623 | -9,499 | 340 | 297 |
| Financing Cash Flow | $5,406 | $-33,540 | $-81,002 | $1,762 | $-78,310 |
| Exchange Rate Effect | -2,862 | 1,642 | 2,804 | 6,552 | -4,658 |
| Beginning Cash Position | 80,106 | 58,761 | 71,679 | 85,963 | 229,592 |
| End Cash Position | 76,449 | 80,106 | 58,761 | 71,679 | 85,963 |
| Net Cash Flow | $-795 | $19,703 | $-15,722 | $-20,836 | $-138,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | 68,957 | 36,280 | 35,939 | 40,481 | 44,618 |
| Capital Expenditure | -33,694 | -31,472 | -9,958 | -25,816 | -224,183 |
| Free Cash Flow | 35,263 | 4,808 | 25,981 | 14,665 | -179,565 |